PEGVISOMANT

PEGVISOMANT was reported 4106 times

These side effects are most commonly reported by patients taking PEGVISOMANT:

# Side effect Count
0 OFF LABEL USE 491
1 DRUG INEFFECTIVE 438
2 HEADACHE 404
3 FATIGUE 387
4 INSULIN-LIKE GROWTH FACTOR INCREASED 380
5 ARTHRALGIA 300
6 PRODUCT DOSE OMISSION ISSUE 268
7 INJECTION SITE PAIN 261
8 DIARRHOEA 256
9 NAUSEA 231
10 PAIN 213
11 BLOOD PRESSURE INCREASED 206
12 NEEDLE ISSUE 204
13 PRODUCT USE ISSUE 203
14 MALAISE 201
15 DEATH 199
16 DIZZINESS 148
17 DIABETES MELLITUS 147
18 INJECTION SITE BRUISING 139
19 BACK PAIN 138
20 BLOOD GROWTH HORMONE INCREASED 135
21 WEIGHT DECREASED 129
22 PERIPHERAL SWELLING 128
23 COUGH 125
24 GAIT DISTURBANCE 123
25 ASTHENIA 122
26 BLOOD GLUCOSE INCREASED 122
27 PAIN IN EXTREMITY 122
28 HYPERHIDROSIS 121
29 FALL 113
30 HEPATIC ENZYME INCREASED 111
31 ABDOMINAL PAIN UPPER 110
32 WEIGHT INCREASED 110
33 DYSPNOEA 107
34 PYREXIA 105
35 HEART RATE DECREASED 104
36 FEELING ABNORMAL 102
37 NASOPHARYNGITIS 101
38 ABDOMINAL PAIN 100
39 CONDITION AGGRAVATED 98
40 NEOPLASM PROGRESSION 96
41 ABDOMINAL DISCOMFORT 94
42 ABDOMINAL DISTENSION 93
43 DECREASED APPETITE 93
44 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 92
45 INJECTION SITE MASS 92
46 URINARY TRACT INFECTION 90
47 CHOLELITHIASIS 88
48 ILLNESS 88
49 ARTHRITIS 87
50 VOMITING 86
51 PNEUMONIA 85
52 STRESS 84
53 CONSTIPATION 83
54 CONTUSION 83
55 INTENTIONAL PRODUCT MISUSE 83
56 BONE PAIN 82
57 HYPOAESTHESIA 79
58 POLYP 75
59 MUSCULOSKELETAL PAIN 74
60 DEVICE LEAKAGE 73
61 COVID-19 72
62 PITUITARY TUMOUR 72
63 JOINT SWELLING 71
64 INSULIN-LIKE GROWTH FACTOR ABNORMAL 70
65 MUSCULAR WEAKNESS 67
66 INJECTION SITE HAEMORRHAGE 66
67 ANXIETY 64
68 BLOOD GLUCOSE DECREASED 64
69 DRUG INTOLERANCE 64
70 INFLUENZA 64
71 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64
72 BLOOD PRESSURE SYSTOLIC INCREASED 62
73 HAEMORRHAGE 62
74 MYALGIA 61
75 DEHYDRATION 60
76 GALLBLADDER DISORDER 59
77 HAEMOGLOBIN DECREASED 59
78 INJECTION SITE REACTION 59
79 ATRIAL FIBRILLATION 58
80 FRUSTRATION TOLERANCE DECREASED 58
81 INSULIN-LIKE GROWTH FACTOR DECREASED 58
82 HELICOBACTER INFECTION 57
83 HYPERTENSION 56
84 CARDIAC FAILURE 55
85 LIMB DISCOMFORT 55
86 LUNG NEOPLASM MALIGNANT 55
87 INJECTION SITE DISCOMFORT 54
88 NEOPLASM 54
89 PITUITARY TUMOUR BENIGN 54
90 CHEST PAIN 53
91 GLYCOSYLATED HAEMOGLOBIN INCREASED 53
92 PRODUCT DOSE OMISSION 53
93 THYROID DISORDER 53
94 ALOPECIA 52
95 HYPERSENSITIVITY 52
96 RASH 52
97 CEREBROVASCULAR ACCIDENT 51
98 INSOMNIA 51
99 PRURITUS 51
100 SWELLING 51
101 UNDERDOSE 51
102 BONE DISORDER 49
103 DYSURIA 49
104 BLOOD CHOLESTEROL INCREASED 48
105 DRUG DOSE OMISSION BY DEVICE 48
106 JAUNDICE 48
107 NEOPLASM MALIGNANT 48
108 DEPRESSION 47
109 MUSCULOSKELETAL DISCOMFORT 47
110 PERIPHERAL COLDNESS 47
111 PRODUCT DOSE OMISSION IN ERROR 47
112 ANAEMIA 46
113 MASS 46
114 FAECES DISCOLOURED 45
115 FURUNCLE 45
116 INCORRECT DOSE ADMINISTERED 45
117 INTESTINAL HAEMORRHAGE 45
118 URINE ODOUR ABNORMAL 45
119 EXOSTOSIS 44
120 MEMORY IMPAIRMENT 44
121 CHANGE OF BOWEL HABIT 43
122 DUODENAL ULCER 43
123 OROPHARYNGEAL PAIN 43
124 URINE ABNORMALITY 43
125 BLADDER DISORDER 42
126 FULL BLOOD COUNT DECREASED 42
127 POSTOPERATIVE WOUND INFECTION 42
128 PROCTALGIA 42
129 SENSITISATION 42
130 SLEEP APNOEA SYNDROME 42
131 SYRINGE ISSUE 42
132 URINARY INCONTINENCE 42
133 ACROMEGALY 41
134 INJECTION SITE SWELLING 41
135 VISUAL IMPAIRMENT 40
136 BLOOD CHOLESTEROL ABNORMAL 38
137 DISEASE PROGRESSION 37
138 LIPOHYPERTROPHY 37
139 NECK PAIN 37
140 PARAESTHESIA 37
141 BRAIN NEOPLASM 36
142 DRUG HYPERSENSITIVITY 36
143 FLATULENCE 36
144 INJECTION SITE ERYTHEMA 36
145 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 35
146 MUSCLE SPASMS 35
147 RECTAL POLYP 35
148 BRADYCARDIA 34
149 GASTROINTESTINAL DISORDER 34
150 POOR QUALITY PRODUCT ADMINISTERED 34
151 RHINORRHOEA 34
152 BLOOD GLUCOSE FLUCTUATION 33
153 DEVICE BREAKAGE 33
154 DEVICE ISSUE 33
155 FEELING COLD 33
156 PRODUCT QUALITY ISSUE 33
157 TREMOR 33
158 VISION BLURRED 33
159 NEPHROLITHIASIS 32
160 SINUSITIS 31
161 CHEST DISCOMFORT 30
162 SEIZURE 30
163 ARTHROPATHY 29
164 INJECTION SITE PRURITUS 29
165 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 29
166 BLOOD TESTOSTERONE DECREASED 28
167 ERYTHEMA 28
168 INJECTION SITE HYPERTROPHY 28
169 MIGRAINE 28
170 NOCTURIA 28
171 AMNESIA 27
172 CARDIAC DISORDER 27
173 LOW DENSITY LIPOPROTEIN INCREASED 27
174 HYPOTENSION 26
175 INTENTIONAL DOSE OMISSION 26
176 URTICARIA 26
177 ALANINE AMINOTRANSFERASE INCREASED 25
178 EATING DISORDER 25
179 HYPOGLYCAEMIA 25
180 INFLUENZA LIKE ILLNESS 25
181 LIMB INJURY 25
182 NASAL CONGESTION 25
183 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25
184 BLOOD THYROID STIMULATING HORMONE DECREASED 24
185 DEVICE DIFFICULT TO USE 24
186 OSTEOARTHRITIS 24
187 SOMNOLENCE 24
188 ASTHMA 23
189 CATARACT 23
190 CONCOMITANT DISEASE AGGRAVATED 23
191 DEVICE PHYSICAL PROPERTY ISSUE 23
192 FEELING HOT 23
193 SYNCOPE 23
194 TACHYCARDIA 23
195 WOUND INFECTION 23
196 BLOOD PRESSURE DECREASED 22
197 CELLULITIS 22
198 DEPRESSED MOOD 22
199 DEVICE DEFECTIVE 22
200 ERUCTATION 22
201 LOSS OF CONSCIOUSNESS 22
202 MYOCARDIAL INFARCTION 22
203 TENDONITIS 22
204 AGITATION 21
205 BLOOD TRIGLYCERIDES INCREASED 21
206 DRUG DOSE OMISSION 21
207 HEART RATE INCREASED 21
208 HYPERGLYCAEMIA 21
209 INJECTION SITE INDURATION 21
210 INJECTION SITE OEDEMA 21
211 LIVER FUNCTION TEST INCREASED 21
212 MUSCULOSKELETAL STIFFNESS 21
213 PRODUCT DISPENSING ERROR 21
214 PULMONARY EMBOLISM 21
215 ARTERIAL OCCLUSIVE DISEASE 20
216 BRONCHITIS 20
217 SPINAL OSTEOARTHRITIS 20
218 THERAPEUTIC RESPONSE UNEXPECTED 20
219 VITAL FUNCTIONS ABNORMAL 20
220 BLOOD GLUCOSE ABNORMAL 19
221 BODY TEMPERATURE DECREASED 19
222 BODY TEMPERATURE INCREASED 19
223 GASTROENTERITIS VIRAL 19
224 HEPATOTOXICITY 19
225 HORMONE LEVEL ABNORMAL 19
226 LIPODYSTROPHY ACQUIRED 19
227 LIVER DISORDER 19
228 OEDEMA PERIPHERAL 19
229 PITUITARY TUMOUR RECURRENT 19
230 PRODUCT COMPLAINT 19
231 TYPE 2 DIABETES MELLITUS 19
232 BRAIN INJURY 18
233 CHILLS 18
234 CONFUSIONAL STATE 18
235 DEVICE MALFUNCTION 18
236 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18
237 DRUG RESISTANCE 18
238 DYSPNOEA EXERTIONAL 18
239 FOOT DEFORMITY 18
240 GROWTH HORMONE-PRODUCING PITUITARY TUMOUR 18
241 LABORATORY TEST ABNORMAL 18
242 LIQUID PRODUCT PHYSICAL ISSUE 18
243 PALPITATIONS 18
244 POOR QUALITY DEVICE USED 18
245 SEPSIS 18
246 THROMBOSIS 18
247 BLOOD PRESSURE FLUCTUATION 17
248 BREAST CANCER 17
249 FAECES SOFT 17
250 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17
251 NERVOUSNESS 17
252 SCIATICA 17
253 THERAPEUTIC RESPONSE DECREASED 17
254 TOOTH ABSCESS 17
255 ARRHYTHMIA 16
256 BLOOD ALKALINE PHOSPHATASE INCREASED 16
257 DRY EYE 16
258 FAT TISSUE INCREASED 16
259 HEPATIC FUNCTION ABNORMAL 16
260 INJECTION SITE INJURY 16
261 PRODUCT USE IN UNAPPROVED INDICATION 16
262 VERTIGO 16
263 BLISTER 15
264 BLOOD PRESSURE ABNORMAL 15
265 BLOOD PROLACTIN INCREASED 15
266 BREATH ODOUR 15
267 DISEASE RECURRENCE 15
268 EAR PAIN 15
269 EYE MOVEMENT DISORDER 15
270 GASTRIC HYPOMOTILITY 15
271 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15
272 INFREQUENT BOWEL MOVEMENTS 15
273 MENTAL DISORDER 15
274 OBSESSIVE-COMPULSIVE DISORDER 15
275 RENAL CYST 15
276 RENAL FAILURE 15
277 RENAL HAEMATOMA 15
278 RENAL IMPAIRMENT 15
279 SHUNT MALFUNCTION 15
280 SHUNT OCCLUSION 15
281 STRABISMUS 15
282 TREATMENT FAILURE 15
283 TREATMENT NONCOMPLIANCE 15
284 VIRAL DIARRHOEA 15
285 ASPARTATE AMINOTRANSFERASE INCREASED 14
286 BLOOD SODIUM DECREASED 14
287 BLOOD TEST ABNORMAL 14
288 CALCINOSIS 14
289 EYE PAIN 14
290 HEPATITIS 14
291 HIP ARTHROPLASTY 14
292 LACTOSE INTOLERANCE 14
293 LETHARGY 14
294 LIVER FUNCTION TEST ABNORMAL 14
295 PRESCRIBED OVERDOSE 14
296 SLEEP DISORDER 14
297 TRANSIENT ISCHAEMIC ATTACK 14
298 BLINDNESS 13
299 BLOOD CREATININE INCREASED 13
300 BLOOD IRON DECREASED 13
301 DRUG EFFECT INCOMPLETE 13
302 DRY SKIN 13
303 DYSPEPSIA 13
304 GENERAL PHYSICAL HEALTH DETERIORATION 13
305 HEPATIC ENZYME ABNORMAL 13
306 HYPOACUSIS 13
307 HYPOTHYROIDISM 13
308 INFECTION 13
309 OVERDOSE 13
310 PAIN IN JAW 13
311 PANCREATITIS 13
312 POLYURIA 13
313 PRODUCT PRESCRIBING ERROR 13
314 PYELONEPHRITIS 13
315 RENAL DISORDER 13
316 SPEECH DISORDER 13
317 SWELLING FACE 13
318 VITAMIN D DECREASED 13
319 BLOOD UREA INCREASED 12
320 DIVERTICULITIS 12
321 GASTRIC DISORDER 12
322 HIP FRACTURE 12
323 HYPOTHALAMO-PITUITARY DISORDER 12
324 INFLAMMATION 12
325 INJECTION SITE RASH 12
326 INTENTIONAL PRODUCT USE ISSUE 12
327 JOINT INJURY 12
328 MOBILITY DECREASED 12
329 NEOPLASM RECURRENCE 12
330 RED BLOOD CELL COUNT DECREASED 12
331 ROAD TRAFFIC ACCIDENT 12
332 BLOOD POTASSIUM DECREASED 11
333 BLOOD PROLACTIN DECREASED 11
334 BONE DENSITY INCREASED 11
335 CHROMATURIA 11
336 DEVICE USE ISSUE 11
337 EPISTAXIS 11
338 FAECES PALE 11
339 FLUID RETENTION 11
340 GASTROOESOPHAGEAL REFLUX DISEASE 11
341 HAEMATOCRIT DECREASED 11
342 HOT FLUSH 11
343 INJECTION SITE EROSION 11
344 OCULAR DISCOMFORT 11
345 PRODUCT PHYSICAL ISSUE 11
346 PRODUCT PREPARATION ISSUE 11
347 SKIN DISORDER 11
348 SWOLLEN TONGUE 11
349 ACNE 10
350 ADRENAL INSUFFICIENCY 10
351 ADRENOCORTICAL INSUFFICIENCY ACUTE 10
352 BALANCE DISORDER 10
353 BLOOD BILIRUBIN INCREASED 10
354 BLOOD CALCIUM DECREASED 10
355 BLOOD PRESSURE DIASTOLIC INCREASED 10
356 BURSITIS 10
357 CHOLECYSTECTOMY 10
358 DIABETES MELLITUS INADEQUATE CONTROL 10
359 DISCOMFORT 10
360 DYSPHAGIA 10
361 EMOTIONAL DISORDER 10
362 ERECTILE DYSFUNCTION 10
363 GAIT INABILITY 10
364 GLUCOSE TOLERANCE IMPAIRED 10
365 HAEMATOCHEZIA 10
366 HEPATIC CIRRHOSIS 10
367 INJECTION SITE HAEMATOMA 10
368 MATERNAL EXPOSURE DURING PREGNANCY 10
369 NEUROPATHY PERIPHERAL 10
370 NIGHT SWEATS 10
371 OXYGEN SATURATION DECREASED 10
372 PRODUCT PREPARATION ERROR 10
373 RASH PAPULAR 10
374 THERAPY NON-RESPONDER 10
375 ACCIDENTAL EXPOSURE TO PRODUCT 9
376 BACK DISORDER 9
377 BILE DUCT STONE 9
378 BILIARY COLIC 9
379 BLOOD GROWTH HORMONE ABNORMAL 9
380 BLOOD TESTOSTERONE INCREASED 9
381 BLOOD UREA NITROGEN/CREATININE RATIO INCREASED 9
382 CENTRAL OBESITY 9
383 CHOLECYSTITIS 9
384 CHOLECYSTITIS ACUTE 9
385 CYSTITIS 9
386 DIABETES INSIPIDUS 9
387 DISTURBANCE IN ATTENTION 9
388 DYSPHONIA 9
389 EXPOSURE VIA SKIN CONTACT 9
390 GOITRE 9
391 INCORRECT DOSE ADMINISTERED BY DEVICE 9
392 INCORRECT ROUTE OF DRUG ADMINISTRATION 9
393 INFECTED DERMAL CYST 9
394 IRON DEFICIENCY ANAEMIA 9
395 OSTEOPOROSIS 9
396 PITUITARY ENLARGEMENT 9
397 POLYDIPSIA 9
398 PRODUCT STORAGE ERROR 9
399 RECTAL HAEMORRHAGE 9
400 TEMPERATURE INTOLERANCE 9
401 THYROID MASS 9
402 TRANSAMINASES INCREASED 9
403 UPPER LIMB FRACTURE 9
404 WHITE BLOOD CELL COUNT DECREASED 9
405 AFFECTIVE DISORDER 8
406 ANGINA PECTORIS 8
407 ANORECTAL POLYP 8
408 BLOOD CREATININE DECREASED 8
409 BLOOD MAGNESIUM DECREASED 8
410 BLOOD TESTOSTERONE FREE DECREASED 8
411 CARDIAC ARREST 8
412 CARDIAC FAILURE CONGESTIVE 8
413 CARDIOMEGALY 8
414 DEMENTIA 8
415 DYSARTHRIA 8
416 EAR INFECTION 8
417 GLOMERULAR FILTRATION RATE DECREASED 8
418 HERPES ZOSTER 8
419 HIGH DENSITY LIPOPROTEIN DECREASED 8
420 INCORRECT PRODUCT STORAGE 8
421 LYMPHADENOPATHY 8
422 NERVOUS SYSTEM DISORDER 8
423 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 8
424 OEDEMA 8
425 PARALYSIS 8
426 PRODUCT ADMINISTRATION ERROR 8
427 PROGNATHISM 8
428 PROSTATE CANCER 8
429 SKELETAL INJURY 8
430 SKIN HYPERTROPHY 8
431 SNORING 8
432 SUBDURAL HAEMATOMA 8
433 SUICIDAL IDEATION 8
434 SURGERY 8
435 WEIGHT ABNORMAL 8
436 ANGER 7
437 BLOOD PARATHYROID HORMONE INCREASED 7
438 BODY HEIGHT DECREASED 7
439 BRAIN FOG 7
440 BURNING SENSATION 7
441 CEREBRAL HAEMORRHAGE 7
442 COGNITIVE DISORDER 7
443 CORTISOL DECREASED 7
444 DEVICE CONNECTION ISSUE 7
445 DISORIENTATION 7
446 HAEMORRHOIDS 7
447 HEAD DISCOMFORT 7
448 HERNIA 7
449 HUNGER 7
450 HYPOPITUITARISM 7
451 INCONTINENCE 7
452 INJECTION SITE DISCOLOURATION 7
453 INJECTION SITE NODULE 7
454 INJURY ASSOCIATED WITH DEVICE 7
455 JAW DISORDER 7
456 JOINT STIFFNESS 7
457 KNEE ARTHROPLASTY 7
458 LAZINESS 7
459 LIBIDO DECREASED 7
460 LIGAMENT SPRAIN 7
461 MOVEMENT DISORDER 7
462 MULTIPLE SCLEROSIS RELAPSE 7
463 MUSCLE RUPTURE 7
464 MUSCULOSKELETAL CHEST PAIN 7
465 NECK INJURY 7
466 PHOTOPHOBIA 7
467 PLATELET COUNT DECREASED 7
468 POLLAKIURIA 7
469 RED CELL DISTRIBUTION WIDTH INCREASED 7
470 RESPIRATORY FAILURE 7
471 RUBBER SENSITIVITY 7
472 SLUGGISHNESS 7
473 THERAPY CESSATION 7
474 THIRST 7
475 VITAMIN D DEFICIENCY 7
476 ABORTION SPONTANEOUS 6
477 ACUTE KIDNEY INJURY 6
478 ADVERSE DRUG REACTION 6
479 BILE DUCT OBSTRUCTION 6
480 BLOOD CALCIUM INCREASED 6
481 BLOOD LUTEINISING HORMONE DECREASED 6
482 CARPAL TUNNEL SYNDROME 6
483 CHOLANGITIS 6
484 COLITIS 6
485 CRYING 6
486 DEEP VEIN THROMBOSIS 6
487 DEVICE MECHANICAL ISSUE 6
488 DIPLOPIA 6
489 DIVERTICULUM 6
490 DRY MOUTH 6
491 EMOTIONAL DISTRESS 6
492 EXPOSURE DURING PREGNANCY 6
493 EYE DISORDER 6
494 EYE INFLAMMATION 6
495 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6
496 GLAUCOMA 6
497 HORDEOLUM 6
498 HOSPITALISATION 6
499 IMPAIRED GASTRIC EMPTYING 6
500 INJECTION SITE INFLAMMATION 6
501 LARGE INTESTINE POLYP 6
502 MENINGITIS 6
503 MINIMAL RESIDUAL DISEASE 6
504 NEURALGIA 6
505 OCULAR HYPERAEMIA 6
506 PITUITARY GLAND OPERATION 6
507 POOR QUALITY DRUG ADMINISTERED 6
508 POOR QUALITY SLEEP 6
509 PRODUCT CONTAINER ISSUE 6
510 PRODUCT PACKAGING ISSUE 6
511 SKIN DISCOLOURATION 6
512 THYROID CANCER 6
513 TRIGEMINAL NEURALGIA 6
514 UPPER RESPIRATORY TRACT INFECTION 6
515 ABSCESS 5
516 ADENOMA BENIGN 5
517 ANAPHYLACTIC SHOCK 5
518 BLOOD CHLORIDE DECREASED 5
519 BLOOD CHLORIDE INCREASED 5
520 BLOOD GROWTH HORMONE DECREASED 5
521 BLOOD POTASSIUM INCREASED 5
522 BLOOD PRESSURE DIASTOLIC DECREASED 5
523 BOWEL MOVEMENT IRREGULARITY 5
524 CEREBROSPINAL FLUID LEAKAGE 5
525 CHOLECYSTITIS INFECTIVE 5
526 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5
527 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5
528 COLD SWEAT 5
529 DIABETIC KETOACIDOSIS 5
530 DRUG EFFECT DECREASED 5
531 DRUG EFFECT LESS THAN EXPECTED 5
532 DRUG INTERACTION 5
533 EXTRA DOSE ADMINISTERED 5
534 EYE SWELLING 5
535 FEAR OF INJECTION 5
536 FLUSHING 5
537 GASTROINTESTINAL HAEMORRHAGE 5
538 GASTROINTESTINAL PAIN 5
539 HAEMOGLOBIN INCREASED 5
540 HEAD INJURY 5
541 HEART RATE IRREGULAR 5
542 HEPATIC STEATOSIS 5
543 HEPATITIS CHOLESTATIC 5
544 HYPERVENTILATION 5
545 HYPOGONADISM 5
546 INJECTION SITE IRRITATION 5
547 INJECTION SITE SCAR 5
548 INJECTION SITE WARMTH 5
549 INTESTINAL OBSTRUCTION 5
550 IRRITABILITY 5
551 LEUKOPENIA 5
552 MENORRHAGIA 5
553 MENTAL IMPAIRMENT 5
554 MONOCYTE COUNT INCREASED 5
555 MUSCLE TWITCHING 5
556 NODULE 5
557 PANCREATIC CARCINOMA 5
558 PRE-EXISTING CONDITION IMPROVED 5
559 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5
560 PRODUCT SOLUBILITY ABNORMAL 5
561 PRODUCT USE COMPLAINT 5
562 PRODUCTIVE COUGH 5
563 PRURITUS GENERALISED 5
564 PULMONARY OEDEMA 5
565 RESPIRATORY DISORDER 5
566 RHEUMATOID ARTHRITIS 5
567 SEASONAL ALLERGY 5
568 SINUS CONGESTION 5
569 SINUS DISORDER 5
570 THYROID NEOPLASM 5
571 THYROXINE FREE INCREASED 5
572 TINNITUS 5
573 VIRAL INFECTION 5
574 VISUAL ACUITY REDUCED 5
575 WEIGHT FLUCTUATION 5
576 ABDOMINAL HERNIA 4
577 AGGRESSION 4
578 ALBRIGHT^S DISEASE 4
579 AMENORRHOEA 4
580 ANAL FISSURE 4
581 ANXIETY DISORDER 4
582 ASCITES 4
583 BILIARY DILATATION 4
584 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 4
585 BLOOD URINE PRESENT 4
586 CARDIOMYOPATHY 4
587 CHOLESTASIS 4
588 CLOSTRIDIUM DIFFICILE INFECTION 4
589 COLON CANCER 4
590 COMA 4
591 CORONAVIRUS INFECTION 4
592 DEAFNESS 4
593 DERMATITIS ALLERGIC 4
594 DEVICE USE ERROR 4
595 DIALYSIS 4
596 DRUG-INDUCED LIVER INJURY 4
597 EAR DISORDER 4
598 ECLAMPSIA 4
599 ENCEPHALITIS 4
600 EYE INFECTION 4
601 FACIAL PAIN 4
602 FIBROMYALGIA 4
603 FIBROUS DYSPLASIA OF BONE 4
604 FOOT FRACTURE 4
605 HAEMATURIA 4
606 HEAVY MENSTRUAL BLEEDING 4
607 HEPATITIS ACUTE 4
608 HEPATOCELLULAR INJURY 4
609 HIP SURGERY 4
610 HYPONATRAEMIA 4
611 INCREASED APPETITE 4
612 INJECTION SITE ABSCESS 4
613 INJECTION SITE CELLULITIS 4
614 INJECTION SITE HYPERSENSITIVITY 4
615 LICHEN PLANUS 4
616 LOCALISED INFECTION 4
617 LOWER LIMB FRACTURE 4
618 MACULAR DEGENERATION 4
619 MALIGNANT NEOPLASM PROGRESSION 4
620 MOOD ALTERED 4
621 MUSCULOSKELETAL DISORDER 4
622 NERVE INJURY 4
623 PANCREATITIS ACUTE 4
624 PANIC ATTACK 4
625 PHLEBITIS 4
626 POST PROCEDURAL COMPLICATION 4
627 PRESYNCOPE 4
628 PRODUCT ADMINISTRATION INTERRUPTED 4
629 PRODUCT COMMUNICATION ISSUE 4
630 PRODUCT PACKAGING QUANTITY ISSUE 4
631 RASH PRURITIC 4
632 RENAL CANCER 4
633 RENAL FAILURE ACUTE 4
634 SARS-COV-2 TEST POSITIVE 4
635 SEPTIC SHOCK 4
636 SKIN ULCER 4
637 SPINAL OPERATION 4
638 SUBARACHNOID HAEMORRHAGE 4
639 THERAPEUTIC PRODUCT EFFECT DECREASED 4
640 THERAPY INTERRUPTED 4
641 THYROXINE FREE DECREASED 4
642 TONGUE DISORDER 4
643 VENTRICULAR EXTRASYSTOLES 4
644 VERY LOW DENSITY LIPOPROTEIN INCREASED 4
645 VISUAL PATHWAY DISORDER 4
646 ABNORMAL FAECES 3
647 ABSCESS LIMB 3
648 ACOUSTIC NEUROMA 3
649 ADDISON^S DISEASE 3
650 ADRENAL NEOPLASM 3
651 AFFECT LABILITY 3
652 ALBUMIN GLOBULIN RATIO DECREASED 3
653 ALTERED STATE OF CONSCIOUSNESS 3
654 ANGIOEDEMA 3
655 ANKLE FRACTURE 3
656 BACTERIAL INFECTION 3
657 BENIGN PROSTATIC HYPERPLASIA 3
658 BILE DUCT CANCER 3
659 BLOOD ALKALINE PHOSPHATASE DECREASED 3
660 BLOOD BILIRUBIN DECREASED 3
661 BLOOD CREATINE PHOSPHOKINASE INCREASED 3
662 BLOOD SODIUM INCREASED 3
663 BLOOD THYROID STIMULATING HORMONE INCREASED 3
664 BLOOD URIC ACID INCREASED 3
665 BODY HEIGHT INCREASED 3
666 BREAST PAIN 3
667 C-REACTIVE PROTEIN INCREASED 3
668 CARBON DIOXIDE DECREASED 3
669 CARDIAC OPERATION 3
670 CARDIAC VALVE DISEASE 3
671 CHEST INJURY 3
672 CLUSTER HEADACHE 3
673 COLITIS ULCERATIVE 3
674 COLONIC ABSCESS 3
675 CORTISOL INCREASED 3
676 CYST 3
677 DEAFNESS UNILATERAL 3
678 DECREASED IMMUNE RESPONSIVENESS 3
679 DECUBITUS ULCER 3
680 DEFICIENCY OF BILE SECRETION 3
681 DELIRIUM 3
682 DEVICE DISPENSING ERROR 3
683 DIARRHOEA HAEMORRHAGIC 3
684 DISEASE COMPLICATION 3
685 DIZZINESS POSTURAL 3
686 DYSLIPIDAEMIA 3
687 DYSSTASIA 3
688 ENDOCRINE GLAND OPERATION 3
689 EPILEPSY 3
690 EXOPHTHALMOS 3
691 EXTRASYSTOLES 3
692 EYELID PTOSIS 3
693 FAECES HARD 3
694 FEEDING DISORDER 3
695 FEMUR FRACTURE 3
696 FINE MOTOR SKILL DYSFUNCTION 3
697 FLANK PAIN 3
698 FRACTURE 3
699 GASTRIC CANCER 3
700 GESTATIONAL DIABETES 3
701 HAEMATOCRIT INCREASED 3
702 HALLUCINATION 3
703 HEPATIC NEOPLASM 3
704 HEPATOCELLULAR DAMAGE 3
705 HIATUS HERNIA 3
706 HICCUPS 3
707 HYPERSOMNIA 3
708 HYPERTHYROIDISM 3
709 HYPERTRANSAMINASAEMIA 3
710 HYPOTONIA 3
711 HYSTERECTOMY 3
712 ILEUS 3
713 IMPAIRED FASTING GLUCOSE 3
714 INFARCTION 3
715 INJECTION SITE ATROPHY 3
716 INJECTION SITE DISCHARGE 3
717 INJECTION SITE URTICARIA 3
718 INTRACRANIAL ANEURYSM 3
719 JOINT RANGE OF MOTION DECREASED 3
720 KIDNEY INFECTION 3
721 KNEE OPERATION 3
722 LABYRINTHITIS 3
723 LIMB MASS 3
724 LIPIDS INCREASED 3
725 LIVER INJURY 3
726 LOWER RESPIRATORY TRACT INFECTION 3
727 LUNG DISORDER 3
728 MAJOR DEPRESSION 3
729 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3
730 MEAN CELL HAEMOGLOBIN DECREASED 3
731 MOOD SWINGS 3
732 MYOPIA 3
733 NAIL DISORDER 3
734 NEUTROPENIA 3
735 NO ADVERSE EVENT 3
736 NORMAL NEWBORN 3
737 ONYCHOCLASIS 3
738 OSTEOMYELITIS 3
739 OVARIAN CYST 3
740 OXALOSIS 3
741 PALLOR 3
742 PANCREATIC DISORDER 3
743 PANNICULITIS 3
744 PARANASAL SINUS HYPERSECRETION 3
745 PHARYNGITIS 3
746 PNEUMONIA ASPIRATION 3
747 PRODUCT PRESCRIBING ISSUE 3
748 PRODUCT RECONSTITUTION QUALITY ISSUE 3
749 PROTEINURIA 3
750 PSORIASIS 3
751 PSYCHIATRIC SYMPTOM 3
752 PULMONARY MASS 3
753 RASH ERYTHEMATOUS 3
754 RASH MACULAR 3
755 RENAL PAIN 3
756 RETINAL DETACHMENT 3
757 RHINALGIA 3
758 RIB FRACTURE 3
759 SCAB 3
760 SCAR 3
761 SENSATION OF FOREIGN BODY 3
762 SHOULDER OPERATION 3
763 SINUS BRADYCARDIA 3
764 SKIN MASS 3
765 SKIN STRIAE 3
766 SOFT TISSUE SWELLING 3
767 SPINAL DISORDER 3
768 SPINAL FRACTURE 3
769 STOMATITIS 3
770 SUDDEN DEATH 3
771 SUSPECTED OFF LABEL USE 3
772 TENSION 3
773 THINKING ABNORMAL 3
774 THROAT TIGHTNESS 3
775 THROMBOCYTOPENIA 3
776 THYROXINE DECREASED 3
777 TONSILLITIS 3
778 TOOTH INFECTION 3
779 TOOTH LOSS 3
780 TOOTHACHE 3
781 TRI-IODOTHYRONINE DECREASED 3
782 TUMOUR EXCISION 3
783 UNRESPONSIVE TO STIMULI 3
784 URINARY RETENTION 3
785 UTERINE LEIOMYOMA 3
786 VARICOSE VEIN 3
787 VITREOUS FLOATERS 3
788 VULVOVAGINAL MYCOTIC INFECTION 3
789 WHEEZING 3
790 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3
791 ABASIA 2
792 ABDOMINAL INFECTION 2
793 ABDOMINAL TENDERNESS 2
794 ABNORMAL ORGAN GROWTH 2
795 ACIDOSIS 2
796 ADENOCARCINOMA OF COLON 2
797 ADRENAL DISORDER 2
798 ALLERGY TO ANIMAL 2
799 ALPHA 1 FOETOPROTEIN INCREASED 2
800 ANAPHYLACTIC REACTION 2
801 ANAPHYLACTOID REACTION 2
802 AORTIC DISSECTION 2
803 AORTIC VALVE STENOSIS 2
804 APHASIA 2
805 APHONIA 2
806 APHTHOUS ULCER 2
807 APPETITE DISORDER 2
808 APPLICATION SITE PAIN 2
809 ARTHROPOD BITE 2
810 ASPARTATE AMINOTRANSFERASE DECREASED 2
811 ASTIGMATISM 2
812 ATRIAL FLUTTER 2
813 AXILLARY MASS 2
814 BACTERAEMIA 2
815 BEHAVIOUR DISORDER 2
816 BILIARY OBSTRUCTION 2
817 BLADDER CANCER 2
818 BLINDNESS UNILATERAL 2
819 BLOOD ALBUMIN DECREASED 2
820 BLOOD CORTISOL DECREASED 2
821 BLOOD GONADOTROPHIN DECREASED 2
822 BODY DYSMORPHIC DISORDER 2
823 BREAST CANCER FEMALE 2
824 BREAST DISORDER FEMALE 2
825 BREAST TENDERNESS 2
826 BRONCHITIS VIRAL 2
827 CALCIUM DEFICIENCY 2
828 CALCULUS BLADDER 2
829 CARBON DIOXIDE INCREASED 2
830 CARDIAC PACEMAKER INSERTION 2
831 CARDIOVASCULAR DISORDER 2
832 CAVERNOUS SINUS THROMBOSIS 2
833 CEREBRAL INFARCTION 2
834 CHOLANGIOCARCINOMA 2
835 CIRCULATORY COLLAPSE 2
836 CLAVICLE FRACTURE 2
837 CLEFT LIP AND PALATE 2
838 CONCUSSION 2
839 CONJUNCTIVITIS 2
840 CRANIOFACIAL DEFORMITY 2
841 CROHN^S DISEASE 2
842 CYTOLYTIC HEPATITIS 2
843 DECREASED ACTIVITY 2
844 DECREASED INTEREST 2
845 DELUSION 2
846 DEMENTIA ALZHEIMER^S TYPE 2
847 DEPRESSED LEVEL OF CONSCIOUSNESS 2
848 DERMATITIS 2
849 DEVICE CHEMICAL PROPERTY ISSUE 2
850 DEVICE COLOUR ISSUE 2
851 DEVICE DELIVERY SYSTEM ISSUE 2
852 DEVICE RELATED INFECTION 2
853 DILATATION ATRIAL 2
854 DIVERTICULUM INTESTINAL 2
855 DRUG ADMINISTRATION ERROR 2
856 DRUG DEPENDENCE 2
857 DRUG DISPENSING ERROR 2
858 DRUG EFFECT DELAYED 2
859 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2
860 DRUG PRESCRIBING ERROR 2
861 DYSGEUSIA 2
862 DYSMENORRHOEA 2
863 EMPTY SELLA SYNDROME 2
864 ENDOCARDITIS 2
865 ENDOCRINE DISORDER 2
866 ENDOCRINE TEST ABNORMAL 2
867 EOSINOPHIL COUNT INCREASED 2
868 ESSENTIAL TREMOR 2
869 EXERCISE TOLERANCE DECREASED 2
870 FACIAL PARALYSIS 2
871 FAECAL CALPROTECTIN INCREASED 2
872 FEAR 2
873 FIBULA FRACTURE 2
874 FOETAL EXPOSURE DURING PREGNANCY 2
875 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III 2
876 FOOD POISONING 2
877 FUNGAL INFECTION 2
878 GALACTORRHOEA 2
879 GALLBLADDER OPERATION 2
880 GASTRIC ULCER 2
881 GASTROINTESTINAL CARCINOMA 2
882 GASTROINTESTINAL INFECTION 2
883 GASTROINTESTINAL SOUNDS ABNORMAL 2
884 GENERAL PHYSICAL CONDITION ABNORMAL 2
885 GENERALISED TONIC-CLONIC SEIZURE 2
886 GINGIVAL PAIN 2
887 GOUT 2
888 GROIN ABSCESS 2
889 GROWTH ACCELERATED 2
890 GYNAECOMASTIA 2
891 HAEMANGIOMA 2
892 HAEMANGIOMA OF LIVER 2
893 HAIR GROWTH ABNORMAL 2
894 HAIR TEXTURE ABNORMAL 2
895 HAND DEFORMITY 2
896 HEART VALVE INCOMPETENCE 2
897 HEAT STROKE 2
898 HEPATIC CYTOLYSIS 2
899 HEPATIC MASS 2
900 HEPATITIS TOXIC 2
901 HEPATOCELLULAR CARCINOMA 2
902 HYDROCEPHALUS 2
903 HYPERCHOLESTEROLAEMIA 2
904 HYPERKERATOSIS 2
905 HYPERPITUITARISM 2
906 HYPERTENSIVE CRISIS 2
907 HYPERTONIC BLADDER 2
908 HYPERTROPHIC CARDIOMYOPATHY 2
909 HYPERVOLAEMIA 2
910 HYSTEROSALPINGO-OOPHORECTOMY 2
911 ILL-DEFINED DISORDER 2
912 IMMOBILE 2
913 IMMUNE SYSTEM DISORDER 2
914 INCORRECT DOSAGE ADMINISTERED 2
915 INFECTIOUS MONONUCLEOSIS 2
916 INJECTION SITE EXTRAVASATION 2
917 INJECTION SITE VESICLES 2
918 INTERCEPTED PRODUCT PRESCRIBING ERROR 2
919 INTERFERON GAMMA DECREASED 2
920 INTERFERON GAMMA LEVEL INCREASED 2
921 INTERNATIONAL NORMALISED RATIO INCREASED 2
922 INTERVERTEBRAL DISC PROTRUSION 2
923 INTRACARDIAC MASS 2
924 INTRAOCULAR PRESSURE INCREASED 2
925 IRRITABLE BOWEL SYNDROME 2
926 ISCHAEMIC STROKE 2
927 JOINT DISLOCATION 2
928 JOINT LOCK 2
929 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2
930 LABILE BLOOD PRESSURE 2
931 LACK OF INJECTION SITE ROTATION 2
932 LACRIMATION INCREASED 2
933 LARYNGITIS 2
934 LARYNGITIS BACTERIAL 2
935 LARYNGOSPASM 2
936 LEUKAEMIA 2
937 LIBIDO INCREASED 2
938 LIGAMENT RUPTURE 2
939 LIMB OPERATION 2
940 LIP DRY 2
941 LIPOATROPHY 2
942 LIPOMA 2
943 LOCAL SWELLING 2
944 LOCALISED OEDEMA 2
945 LOOSE TOOTH 2
946 LOW DENSITY LIPOPROTEIN DECREASED 2
947 LOWER GASTROINTESTINAL HAEMORRHAGE 2
948 LUMBAR SPINAL STENOSIS 2
949 MALIGNANT MELANOMA 2
950 MALOCCLUSION 2
951 MAMMOGRAM ABNORMAL 2
952 MATERNAL EXPOSURE TIMING UNSPECIFIED 2
953 MENISCUS INJURY 2
954 MENSTRUAL DISORDER 2
955 MENSTRUATION DELAYED 2
956 MICTURITION URGENCY 2
957 MITRAL VALVE INCOMPETENCE 2
958 MOUTH SWELLING 2
959 MUCOUS STOOLS 2
960 MULTIPLE USE OF SINGLE-USE PRODUCT 2
961 MUSCLE HYPERTROPHY 2
962 MUTISM 2
963 NASAL DISORDER 2
964 NASAL POLYPS 2
965 NASAL SEPTUM DISORDER 2
966 NERVE COMPRESSION 2
967 NEUTROPHIL COUNT INCREASED 2
968 OBESITY 2
969 OCULAR NEOPLASM 2
970 OESOPHAGEAL ACHALASIA 2
971 OESOPHAGEAL ULCER 2
972 OSTEOCHONDROMA 2
973 OSTEOPENIA 2
974 OVARIAN CANCER 2
975 OVERWEIGHT 2
976 PANCREATIC CYST 2
977 PANCREATITIS CHRONIC 2
978 PANCYTOPENIA 2
979 PANIC REACTION 2
980 PARANASAL SINUS DISCOMFORT 2
981 PELVIC FLOOR MUSCLE WEAKNESS 2
982 PERIORBITAL OEDEMA 2
983 PHONOPHOBIA 2
984 PHOTOSENSITIVITY REACTION 2
985 PIGMENTATION DISORDER 2
986 PITUITARY HAEMORRHAGE 2
987 PITUITARY STALK INTERRUPTION SYNDROME 2
988 PITUITARY TUMOUR REMOVAL 2
989 PLASMA CELL MYELOMA 2
990 PORTAL VEIN THROMBOSIS 2
991 POST HERPETIC NEURALGIA 2
992 POSTPARTUM HAEMORRHAGE 2
993 PRE-ECLAMPSIA 2
994 PREMATURE BABY 2
995 PREMATURE MENOPAUSE 2
996 PROCEDURAL COMPLICATION 2
997 PRODUCT COLOUR ISSUE 2
998 PRODUCT CONTAMINATION 2
999 PRODUCT DEPOSIT 2